期刊文献+

半胱氨酰白三烯受体CysLT1R在大肠癌组织中的表达及临床意义 被引量:2

Expression of CysLT1R in colorectal carcinoma tissues and its clinical significance
下载PDF
导出
摘要 目的研究半胱氨酰白三烯受体(CysLT1R)在大肠癌组织中的表达及其与大肠癌临床病理特征之间的关系。方法选取46例大肠癌、32例癌旁组织、15例腺瘤性息肉手术切除标本,采用免疫组织化学法检测各组织中CysLT1R的表达水平。结果 CysLT1R在大肠癌组织、癌旁组织及腺瘤性息肉中的阳性表达率分别为67.39%,40.62%,40.0%,癌组织中CysLT1R的阳性表达率高于癌旁组织、腺瘤性息肉组织(P<0.05)。大肠癌组织中CysLT1R的表达程度与肿瘤大小、组织学分级、淋巴结转移及临床分期有关(均P<0.05)。结论 CysLT1R表达与大肠癌分化程度、肿瘤大小、淋巴结转移及临床分期有关。CysLT1R可能参与大肠癌发生发展。 Objective To investigate the expression of CysLT1R protein in tissues of co|orectal carcinoma and its clinical significance. Methods The CysLT1R expression was examined in colorectal carcinoma tissues, para - neoplastic tissues and adenomatous polyp tissues by immunohistochemisty. The association of CysLT1R expression with clinic pathological features was analyzed. Results The positive rate of CysLT1R was significantly higher in colorectal carcinoma tissues than those in para-neoplastic tissues and adenomatous polyp(67.39% vs 40.62%,40.0%,P 〈 0.05 ). The CysLT1R expression was correlated with the tumor size, histological grade, lymph node metastasis and clinical stage in colorectal carcinoma tissues (P 〈 0. 05 ). Conclusion The expression of CysLT1R is positively correlated with the tumor size, histological grade, lymph node metastasis, and may play an important role in the development of colorectal carcinoma.
出处 《山西医科大学学报》 CAS 2014年第3期177-179,247,共4页 Journal of Shanxi Medical University
基金 徐州市科技计划基金资助项目(XM12B044)
关键词 大肠肿瘤 半胱氨酰白三烯受体 免疫组织化学 colorectal neoplasms CysLT1 R immunohistochemistry
  • 相关文献

参考文献9

  • 1Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer[ J ]. Gastroenterology ,2010,138 (6) :2101 - 2114.
  • 2Wang D, Dubois RN. Eicosanoids and cancer [ J ]. Nat Rev Cancer,2010,10 ( 3 ) : 181 - 193.
  • 3Ziek SM, Turgeon DK, Vareed SK, et al. Phase II study of the effects of Ginger root extract on eicosanoids in colon mueosa in people at normal risk for colorectal cancer[ J]. Cancer Prey Res, 2011,4 ( 11 ) : 1929 - 1937.
  • 4Nielsen CK, Ohd JF, Wikstrom K, et al. The leukotriene receptor CysLT1 and 5 - lipnxygenase are upregulated in colon cancer [ J ]. Adv Exp Med Biol,2003,525:201 - 204.
  • 5张瑛,郝飞,钟华,钟白玉,唐书谦.半胱氨酰白三烯受体在几种表皮肿瘤及瘤样病变中的表达及意义[J].第三军医大学学报,2007,29(24):2354-2356. 被引量:2
  • 6Edwards BK, Ward E, Kohler BA,et al. Annual report to the na- tion on the status of cancer, 1975 -2006, featuring colorectal cancer trends and impact of interventions ( risk factors, screening, and treatment) to reduce future rates [ J]. Cancer, 2010, 116 (3) :544 -573.
  • 7Tong WG,Ding XZ,Hennig R,et al. Leukotriene B4 receptor an- tagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer ceils [ J ]. Clin Cancer Res, 2002,8 (10) :3232 -3242.
  • 8Schwartz GK, Weitzman A, O' Reilly E,et al. Phase I and phar- macokinetic study of LY293111, an orally bioavailable LTB4 re- ceptor antagonist, in patients with advanced solid tumors [ J ]. J Clin Onco1,2005,23 ( 23 ) :5365 - 5373.
  • 9Melstrom LG, Bentrem DJ, Salabat MR, et al. Overexpression of 5 - Lipoxygenase in colon polyps and cancer and the effect of 5 - LOX inhibitors in vitro and in a murine model [ J ]. Clin Cancer Res, 2008,14(20) :6525 -6530.

二级参考文献10

  • 1钟华,郝飞,向明明.湿疹患者血清和皮损内白三烯水平测定[J].中华皮肤科杂志,2005,38(11):702-703. 被引量:20
  • 2钟华,郝飞,钟白玉,唐书谦.亚急性湿疹和银屑病患者皮损中半胱氨酰白三烯受体的表达[J].中华皮肤科杂志,2006,39(11):629-631. 被引量:11
  • 3Nielsen C K, Ohd J F, Wikstrom K, et al. The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer[ J ]. Adv Exp Med Biol, 2003, 525:201 -204.
  • 4Paruchuri S, Mezhybovska M, Juhas M, et al. Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells [ J ]. Oncogene, 2006, 25 (50) : 6660 - 6665.
  • 5Mezhybovska M, Wikstrom K, Ohd J F, et al. The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells [ J ]. J Biol Chem, 2006, 281( 10): 6776-6784.
  • 6Coleman R A, Eglen R M, Jones R L, et al. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature [ J ]. Adv Prostaglandin Thromboxane Leukot Res, 1995, 23:283-285.
  • 7Zhong H, Hao F, Xiang M M, et al. Evaluation and interference of serum and skin lesion levels of leukotrienes in patients with eczema[ J ]. Prostaglandins Leukot Essent Fatty Acids, 2006, 75 ( 1 ) : 51 -55.
  • 8Adamek-Guzik T, Guzik T J, Czerniawska-Mysik G, et al. Urinary leukotriene levels are increased during exacerbation of atopic eczema/dermatitis syndrome. Relation to clinical status[ J ]. Allergy, 2002, 57 ( 8 ) : 732 - 736.
  • 9Nielsen C K, Campbell J I, Ohd J F, et al. A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells[J]. Cancer Res, 2005, 65 (5) : 732-742.
  • 10林熙然.白三烯修饰剂治疗异位性皮炎及其他皮肤病[J].世界核心医学期刊文摘(皮肤病学分册),2005,1(5):1-3. 被引量:1

共引文献1

同被引文献13

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部